By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
Panelists agree that Rocket Lab (RKLB) is the only liquid, investable asset due to SpaceX's private status. They debate SpaceX's (SPCX) valuation, Starlink's profitability, and regulatory risks, with mixed views on its long-term prospects.
Risk: SpaceX's private funding/dilution risk and regulatory moat vulnerability
Opportunity: Rocket Lab's pure-play exposure to the launch and space systems market
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
The space economy has produced two very different public bets. Space Exploration Technologies Corp (NASDAQ: SPCX) is the dominant giant that reshaped the entire industry, while Rocket Lab (NASDAQ: RKLB) is the nimble challenger trying to become a smaller version of it. Both are tempting, but for an investor thinking five years out, I come down firmly on the side of SpaceX.
The single biggest difference between these two companies is Starlink. SpaceX's satellite-internet service already serves more than 10 million customers, generates the bulk of the company's revenue, and is its profit engine. It is a genuine, scaling business with a global runway, and SpaceX pegs its long-term connectivity opportunity in the trillions of dollars.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
Rocket Lab has nothing remotely comparable yet. It earns real revenue launching rockets and building satellites, which is impressive, but it is not yet consistently profitable and is still in the earlier chapters of its story. Over five years, owning the company that already prints cash is a meaningful advantage.
SpaceX does not just compete in launch; it dominates it, sending more rockets to orbit than the rest of the world combined. That scale is self-reinforcing. Cheap, frequent, reusable launches let SpaceX deploy its own Starlink satellites at a cost no rival can match, which funds more launches and more satellites.
Rocket Lab is chasing that flywheel with its larger Neutron rocket, but Neutron has not even flown yet, with its debut still ahead. For the next five years, SpaceX will be executing a proven model at massive scale while Rocket Lab is trying to prove a new rocket works. That gap matters.
SpaceX also carries enormous long-term optionality. Its Starship program aims to slash the cost of reaching space, its direct-to-cell effort could turn ordinary phones into satellite devices, and it is even exploring computing in orbit. Any one of these could open a market worth tens of billions.
Rocket Lab has its own promising expansion plans, including a push to operate satellites through acquisitions, but it simply cannot match SpaceX's breadth or firepower right now. When you own a stock for years, that kind of multi-front optionality is exactly what you want working in your favor.
To be fair, Rocket Lab has real appeal. It is a far smaller company, so a successful Neutron launch and a growing backlog could drive faster percentage gains than a company of SpaceX's size. For aggressive investors, that higher-torque potential is genuine. SpaceX is not risk-free either. Even after falling roughly 50% from its high, it still trades at a rich valuation, and much of its promise depends on Starship and connectivity delivering over time. Both stocks are volatile and hinge on flawless execution in a brutally hard industry.
Weighing it all, I think SpaceX is the better space stock to own for the next five years. It pairs a proven, profitable Starlink engine with total dominance in launch and optionality that few companies anywhere can match. Also, consider how far the froth has drained: SpaceX has tumbled roughly 50% from its June high and now trades below its IPO price at an all-time low, a brutal reset for a stock that once looked priced for perfection. This recent pullback has made the entry point more reasonable than it was at its debut. For the market's dominant cash-generating space leader, that kind of drawdown is exactly when patient investors can quietly begin accumulating shares rather than chasing them, buying a great franchise while the crowd has soured on it.
Rocket Lab is the more exciting turnaround-style bet, and it could reward risk-tolerant investors if Neutron succeeds, but it is earlier, smaller, and less proven. For most people building a five-year position, it's better to own the established leader with the cash-generating business than the promising upstart still trying to reach that stage. Size your investment for volatility, because space is never a smooth ride, but the dominant franchise is where I would put my money.
Before you buy stock in Space Exploration Technologies, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Space Exploration Technologies wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $395,463! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,268,290!
Now, it’s worth noting Stock Advisor’s total average return is 927% — a market-crushing outperformance compared to 211% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of August 4, 2026. *
Micah Zimmerman has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Rocket Lab. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"Public investors cannot actually buy SpaceX shares, making the article's core recommendation practically irrelevant for anyone reading it."
The article pushes SpaceX (SPCX) as the superior 5-year hold over Rocket Lab (RKLB) due to Starlink cash flow, launch dominance, and Starship optionality, especially after its 50% pullback. Yet it glosses over that SpaceX remains a private company despite the NASDAQ: SPCX ticker (which appears to be a placeholder or SPAC artifact); public investors cannot buy it directly. RKLB is the only liquid pure-play equity here. The piece also underplays regulatory risks to Starlink spectrum/approvals, Starship's repeated test failures/delays, and Rocket Lab's faster path to Neutron revenue if it avoids capital raises that dilute shareholders. Valuation for both is opaque given limited disclosures.
If Starship achieves even partial success and Starlink hits 50M+ subscribers by 2028, SpaceX's enterprise value could compound far faster than any public proxy, rendering RKLB a distant second; the article's caution on size and execution risk for Rocket Lab may prove exactly right.
"Investors must distinguish between the operational excellence of SpaceX and the actual, accessible liquidity of Rocket Lab, as the former is not currently a public equity."
The article presents a false dichotomy by treating SpaceX as a publicly traded 'stock' (SPCX) when it is, in fact, a private company. This is a critical error that misleads retail investors regarding liquidity and valuation. While the bull case for SpaceX’s Starlink-driven cash flow is structurally sound, the '50% pullback' narrative is speculative at best, given the lack of public trading data. Rocket Lab (RKLB) is the only actual investable asset here. RKLB offers pure-play exposure to the launch and space systems market, currently trading at a roughly $8-9 billion market cap. The real risk isn't just Neutron's success; it's the margin compression inherent in the commoditization of launch services as competition intensifies.
If SpaceX eventually goes public, its massive scale and vertical integration could render smaller players like Rocket Lab irrelevant by monopolizing launch cadence and orbital slots.
"The article's case for SpaceX rests on Starlink's profitability, but without public financials, the claim that it 'prints cash' is speculative and may mask deteriorating unit economics as subscriber growth plateaus."
The article conflates valuation reset with investment merit. Yes, SpaceX fell 50% — but from what multiple? The piece never states it. If SpaceX trades 'below IPO price,' that's a private-market anchor, not a public-market valuation floor. More critically: Starlink's 10M subscribers generating 'bulk of revenue' is vague. What's the actual margin? Satellite internet is brutally capital-intensive; Starlink's path to the 'trillions' depends on sustained capex that could dwarf near-term cash generation. Meanwhile, the article dismisses Rocket Lab's optionality (Neutron, satellite ops) as inferior without quantifying TAM or probability-weighted upside. For a 5-year horizon, execution risk on Starship is being underweighted.
SpaceX's Starlink margin profile and capex intensity are unknown to public investors — the company is private. The 50% pullback could reflect justified repricing of that unit economics, not a bargain.
"The article’s bullish SpaceX case relies on a false public-market framing and an unproven profit engine—the real test is RKLB and other public space plays, given SpaceX’s private status and Starlink uncertainties."
Strongest issue: SpaceX is not publicly traded; SPCX as a ticker is a misframing. The article stacks a public stock comparison against a private, high-valuation entity, which distorts risk/return math. Even if we overlook that, the claim that Starlink is a profitable cash engine isn’t verifiable publicly and relies on ongoing capex, subsidies, and favorable regulatory dynamics that could reverse. Starship/Neutron cost trajectories remain unproven, and a slowdown in Starlink monetization or regulatory hurdles could erode cash flow. Rocket Lab could still surprise on Neutron milestones and backlog, but the article understates the execution risk and the volatility of space-capital cycles.
Even if SpaceX were public, the Starlink profitability thesis hinges on assumptions that may not hold (costs, subs growth, subsidies); a single delay or cost spike could undermine the five-year bull case.
"Starlink's regulatory first-mover advantage outweighs near-term capex intensity that Claude flags."
Claude's margin skepticism is fair but incomplete: even at 40% gross margins on Starlink (plausible per leaked docs), $4-5B annual FCF by 2028 funds Starship iteration with room for dilution-free growth. The real gap nobody quantified is regulatory moat—FCC/ITU spectrum approvals give SpaceX 3-5 year lead time Rocket Lab cannot close via Neutron alone.
"SpaceX's regulatory moat is a geopolitical liability that could hinder global scaling compared to more localized, smaller-scale competitors like Rocket Lab."
Grok, your focus on the regulatory moat ignores the 'sovereign risk' inherent in Starlink. Relying on FCC/ITU approvals for global dominance is a geopolitical vulnerability, not just a competitive advantage. If foreign governments mandate local satellite partnerships or restrict spectrum access, SpaceX’s 'lead time' evaporates. Meanwhile, Rocket Lab’s smaller, adaptable footprint is better positioned to navigate these fragmented, protectionist regulatory environments. The moat is a potential anchor if international markets pivot toward domestic space sovereignty.
"Geopolitical risk is real, but it doesn't eliminate SpaceX's core addressable market in the US and allied nations."
Gemini's sovereign-risk pivot is sharp, but it conflates two separate problems. Yes, geopolitical fragmentation threatens Starlink's *global* TAM. But SpaceX still captures US/allied markets—the highest-margin segment—regardless. Rocket Lab's 'adaptability' is theoretical; it has zero track record navigating protectionist regimes. The real question: does Starlink need 80% global penetration to justify its valuation, or does 40% of developed markets suffice? Nobody's modeled that threshold.
"SpaceX’s private funding/dilution risk undermines the SpaceX bull case and requires explicit attention in a 5-year horizon."
Responding to Gemini: Sovereign risk matters, but the bigger flaw is not quantifying SpaceX’s private funding/dilution risk. Starlink capex plus Starship iterations require repeated financings; the current '50% pullback' may reflect private-market dilution risk, not a buying opportunity for public investors. RKLB is liquid today; its value hinges on Neutron cadence and margin, not SpaceX’s private moat. In a 5-year frame, liquidity and dilution risk for SpaceX deserve explicit treatment.
Panelists agree that Rocket Lab (RKLB) is the only liquid, investable asset due to SpaceX's private status. They debate SpaceX's (SPCX) valuation, Starlink's profitability, and regulatory risks, with mixed views on its long-term prospects.
Rocket Lab's pure-play exposure to the launch and space systems market
SpaceX's private funding/dilution risk and regulatory moat vulnerability